Divi's Laboratories PE Ratio

PE ratio as of May 2025 (TTM) : 78.04 | Industry PE : 45.08
Last Updated Date: 14th May, 2025

Divi's Laboratories PE ratio analysis

  • PE Ratio of Divi's Laboratories has increased by 38.60% compared to the previous Financial Year.
  • PE Ratio with value of 57.02 was highest in Year 2024 in the last 5 years.
  • PE Ratio with value of 38.33 was lowest in Year 2020 in the last 5 years.
  • Latest PE Ratio with value of 57.02 is higher than the Average PE of 44.91 in the last 5 years.

Historical P/E Ratio of Divi's Laboratories

Divi's Laboratories PE ratio at the end of each year

YearP/E RatioChange
202457.02+38.60%
202341.14+4.18%
202239.49-18.68%
202148.56+26.69%
202038.33--

PE Ratio Comparison with Peers of Divi's Laboratories

Peers & ReturnsMarket CapitalizationPE Ratio
Laurus Labs33,463.31 Cr92.30
Suven Pharmaceuticals28,910.94 Cr57.34
Torrent Pharmaceuticals1,10,170.76 Cr53.15
Mankind Pharma98,432.98 Cr48.11
Ipca Laboratories34,965.52 Cr47.96
GlaxoSmithKline Pharmaceuticals48,328.15 Cr47.23

Disclaimer: The figures and information provided are for informational purposes only and may vary over time. The above data may be outdated and not reflect the latest updates. Always conduct thorough research and consult a financial advisor before making any investment decisions.

Data Source - Dion Global Solutions Limited